,25–29 In 2012, Hope et al.28and Heath et al.12used panitumumab-IRDye800CW, a humanized, fluorescently labeled antibody that binds EGFR to image microscopic head and neck cancer in an orthotopic murine mode and was able to detect high fluorescence levels at the malignant site. This evidence concerns the gene EGFR and head and neck cancer.